Omarigliptin Tablets 25mg (Marizev® / マリゼブ錠25mg)

JPY ¥16,000

Japanese long-acting selective DPP-4 inhibitor (Omarigliptin 25mg). Oral once-weekly tablet for the treatment of type 2 diabetes mellitus. 20 tablets [2-tablet blister sheet (PTP with patient package) x 10]. Mfd. by Kissei Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥14,720
10 - 19 12% JPY ¥14,080
20 + 18% JPY ¥13,120
SKU: MRZ-25-TAB Category:

Description

Product Overview / 商品概要

Marizev Tablets 25mg (マリゼブ錠25mg)
Generic: Omarigliptin / オマリグリプチン
Therapeutic Category: Long-acting selective DPP-4 inhibitor, Oral antidiabetic agent / 持続性選択的DPP-4阻害剤、経口糖尿病用剤
Manufactured by: Kissei Pharmaceutical Co., Ltd. / キッセイ薬品工業株式会社

Composition & Specification / 組成・規格

Active Ingredient: Omarigliptin 25mg per tablet / オマリグリプチン 25mg
Additives: D-mannitol, Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, Carnauba wax, Hypromellose, Hydroxypropylcellulose, Titanium dioxide / D-マンニトール、結晶セルロース、クロスカルメロースナトリウム、ステアリン酸マグネシウム、カルナウバロウ、ヒプロメロース、ヒドロキシプロピルセルロース、酸化チタン
Appearance: Almond-shaped film-coated tablet, white, major axis 9.6mm, minor axis 5.6mm, thickness approx. 4.0mm, weight approx. 166mg, identification code: K782
外観: アーモンド形・フィルムコーティング錠、白色、長径9.6mm、短径5.6mm、厚さ約4.0mm、質量約166mg、識別コード:Ⓚ782

Indications / 効能効果

EN: Type 2 diabetes mellitus
JA: 2型糖尿病

Dosage and Administration / 用法用量

EN: The usual adult dose is 25mg of omarigliptin administered orally once weekly.
JA: 通常、成人にはオマリグリプチンとして25mgを1週間に1回経口投与する。

Contraindications / 禁忌

EN: (1) Patients with a history of hypersensitivity to any component of this product; (2) Patients with severe ketosis, diabetic coma or pre-coma, or type 1 diabetes mellitus; (3) Patients with severe infections, perioperative state, or serious trauma requiring insulin therapy for glycemic control
JA: (1)本剤の成分に対し過敏症の既往歴のある患者、(2)重症ケトーシス、糖尿病性昏睡又は前昏睡、1型糖尿病の患者、(3)インスリン注射による血糖管理が望まれる重症感染症、手術前後、重篤な外傷のある患者

Regulatory Information / 規制情報

Approval No.: 22700AMX01015000
Sales Started: November 2015 / 2015年11月
Classification Code: 873969
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 20 tablets [2-tablet blister sheet (PTP with patient package) x 10] / 20錠[2錠シート(患者さん用パッケージ付きPTP)×10]
Other Available Packages (by special order): 20 tablets [2-tablet blister sheet (PTP with patient package) x 10]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Omarigliptin Tablets 25mg (Marizev® / マリゼブ錠25mg)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Omarigliptin Tablets 25mg (Marizev®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.